John A. Galloway
endocrinologist
≈ 2 min read
Names in other languages
- astJohn A. Galloway
- caJohn A. Galloway
- EnglishJohn A. Galloway
- EspañolJohn A. Galloway
- FrançaisJohn A. Galloway
- gaJohn A. Galloway
- mulJohn A. Galloway
- NederlandsJohn A. Galloway
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
John A. Galloway MD (December 8, 1928 – April 4, 2025) was an American endocrinologist who made major contributions to the study and treatment of diabetes. He was clinical research fellow and principal physician in charge of diabetes-related research at the Lilly Laboratory for Clinical Research.
The holder of four patents and author of over 80 publications, Galloway also served as Professor of Medicine at the Indiana University School of Medicine. Galloway died on April 4, 2025, at the age of 96.
RE Chance, BH Frank, JA Galloway: Pharmaceutical Formulations Comprising Human Insulin, Human C-Peptide, and Human Proinsulin, U.S. Patent No. 4,652,548, issued March 24, 1987 RE Chance, BH Frank, JA Galloway: Pharmaceutical Formulation Comprising Human Insulin and Human Proinsulin, U.S. Patent No. 4,652,547, issued March 24, 1987 RE Chance, BH Frank, JA Galloway, Human Proinsulin Pharmaceutical Formulations, U.S. Patent No. 4,654,324, issued March 31, 1987 JA Galloway and JA Hoffmann: Glucagon-like Insulinotropic Peptide (“GLIP”), Composition and Methods, U.S. Patent No. 5,705,483, issued Jan. 6, 1998
Text derived from https://en.wikipedia.org/w/index.php?oldid=1305001135 under CC BY-SA 4.0; modifications have been made.
References
1 claim could not be tied to a specific sentence and is listed in the table below instead.